InflaRx N.V. (IFRX) - Earnings growth in current year
InflaRx N.V. aims to capture the niche of rare pathology and virus therapy by developing unique C5a inhibitors. The 12-month relative EPS growth metric in the GURU.Markets terminal reflects the dynamics of these ambitions, where 66.90 shows the current value of the indicator. Financial stability is based on government grants that minimize capital risks, while the high cost of emergency care drugs amid limited government procurement impacts the final margin.
Analytical breakdowns and data insights for company inflarx.de (IFRX)
- price and consensus price forecast:
- market capitalization indicators:
- book capitalization data:
- debt and liquidity details:
- earnings and market ratios statistics:
IFRX - Company Net Income|Expected Net Income InflaRx N.V.|IFRX - Price to Earnings Ratio|Price to Future Earnings Ratio InflaRx|IFRX - Price/Earnings to Growth Multiple|Business Value to Operating Income Before Depreciation IFRX|IFRX - Profit before payment of interest, taxes and amortization|Earnings per share for the last 12 months InflaRx|IFRX - Net earnings per share for the last 12 months|Year-over-year net earnings per share change for the last twelve months inflarx.de|IFRX - Net earnings per share growth this year|Net earnings per share growth forecast for next year InflaRx N.V.
Fundamental valuation:InflaRx GmbH IFRX
Long-term investing requires strict control of entry points to avoid capital stagnation. In the case of InflaRx N.V. (IFRX), the monetization of unique antibodies for the treatment of autoimmune diseases becomes the key factor. By analyzing the YoY earnings per share (EPS) dynamics, an investor assesses the annual growth rate of net income relative to previous periods. This metric compares market demand with the business's operating expenses. A positive trend confirms the resilience of the company's proprietary ecosystem.
Main competitors
Net earnings per share growth this year argenx N.V.|Net earnings per share growth this year BNTX|Earnings growth in current year abivax.com|Earnings per share growth in current year ADMA Biologics (ADMA)|protagonist-inc.com - Earnings per share growth this year|Earnings growth in current year IMVT (Immunovant)|Kiniksa Pharmaceuticals, Ltd. (KNSA) - Earnings per share growth rate in current year|Grifols Group - Earnings growth in current year|Expected net earnings per share growth this year Adaptive Biotechnologies Inc. ADPT|Celldex Therapeutics (CLDX) - Earnings per share growth in current year|Earnings per share growth this year AUPH|BCRX (BioCryst Pharmaceuticals) - Earnings growth in current year|Vera Therapeutics Inc - Earnings per share trend in current year|Earnings per share growth in current year Dianthus Pharma (DNTH)|Earnings per share growth in current year PHVS (Pharvaris Pharma)|Earnings growth in current year ABCL (AbCellera Biologics)|Earnings growth in current year tourmalinebio.com TRML|PGEN - Earnings per share growth in current year|Earnings per share increase in current year PHAR (Pharming Group NV)|NKTR (Nektar) - Net earnings per share growth this year|Earnings per share growth this year UPB|Net earnings per share growth this year ZBIO|IMNM: Earnings per share increase in current year|Earnings per share growth in current year Gossamer Bio (GOSS)|KalVista Pharma - Earnings per share growth this year|Septerna Corp - Net earnings per share growth this year|Expected net earnings per share growth this year Pieris Corp (PVLA)|SVRA: Net earnings per share growth this year|RIGL: Earnings per share growth in current year|ANAB (AnaptysBio) - Net earnings per share growth this year|ATXS - Expected net earnings per share growth this year|ENGN (enGene Bio) - Earnings growth in current year|RAPT Therapeutics Inc. (RAPT) - Expected net earnings per share growth this year|Earnings growth in current year JBIO|ACRS: Earnings per share trend in current year|Earnings per share growth in current year Kyverna Therapeutics, Inc. KYTX|Earnings per share increase in current year TLSA|CABA: Net earnings per share growth this year|VTYX (Ventyx Biosciences, Inc) - Earnings per share growth this year|Theratechnologies Inc. (THTX) - Earnings per share growth in current year|Earnings per share trend in current year AVTX (avalotx.com)|ELDN (Eledon Pharmaceuticals, Inc.) - Earnings growth in current year|AGEN: Earnings per share increase in current year|Earnings growth in current year CLYM|Earnings growth in current year Zura Bio Ltd (ZURA)|Earnings per share growth in current year aTyr Pharma, Inc. ATYR|Earnings per share increase in current year ADAG|IMA - Earnings per share growth in current year|Shattuck Labs, Inc. (STTK) - Net earnings per share growth this year|EQ: Earnings growth in current year|Connect Biopharma Holdings Limited (CNTB) - Earnings growth in current year|Net earnings per share growth this year IMUX|ATRA: Earnings per share increase in current year|Earnings growth in current year XFOR|Expected net earnings per share growth this year adicetbio.com|Earnings per share growth in current year Celularity CELU|INMB - Net earnings per share growth this year|BRNS - Earnings per share growth in current year|kezarlifesciences.com (KZR) - Net earnings per share growth this year|SABS (SAB Biotherapeutics, Inc.) - Net earnings per share growth this year|Akari Therapeutics PLC (AKTX) - Earnings growth in current year|Earnings per share growth in current year Enlivex Therapeutics Ltd|Earnings per share growth this year QTTB (Q32 Bio Corp)|Earnings growth in current year GOVX|EDSA - Earnings per share growth rate in current year|Earnings growth in current year IBIO (iBio)|Expected net earnings per share growth this year Carisma Therapeutics Inc (CARM)|XTLB - Earnings per share growth in current year|BOLT (Bolt Biotherapeutics) - Earnings per share growth this year|HCWB: Earnings growth in current year|Earnings per share trend in current year APVO (Aptevo Therapeutics Inc.)|Earnings per share growth in current year AIM ImmunoTech Inc.|Earnings per share growth in current year ADTX|Earnings growth in current year GRI|Earnings growth in current year XORTX Corp (XRTX)|Earnings per share growth in current year Vyome Holdings Inc HIND|Earnings per share increase in current year REVB|INDP: Net earnings per share growth this year|SCNI (Scinai Immunotherapeutics Ltd) - Earnings per share growth this year|CALI (calcimedica.com) - Net earnings per share growth this year|Affimed N.V. - Earnings per share increase in current year|Earnings per share growth in current year Allakos Inc|Earnings per share growth this year HOOK (HOOKIPA)|Net earnings per share growth this year IGMS (IGM Biosciences, Inc.)|Expected net earnings per share growth this year iTeos Therapeutics Inc|Ocean Bio - Net earnings per share growth this year|TC BioPharm Ltd - Earnings per share growth in current year|THRD: Net earnings per share growth this year
